Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes
Clinical trial NCT03222856 · COMPLETED
Trial details
- NCT number
- NCT03222856
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2018-10-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.